Skip to content

Changing Developmental Trajectories Through Early Treatment

Autism Center of Excellence: Project 3 - Changing Developmental Trajectories Through Early Treatment

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01985022
Enrollment
33
Registered
2013-11-15
Start date
2013-05-31
Completion date
2019-11-26
Last updated
2023-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorders

Keywords

autism, pervasive developmental disorders, toddlers, behavioral intervention

Brief summary

The major objective of this research protocol is to directly compare two parent intervention conditions of Early Social Interaction (ESI) for 9 months on developmental trajectories of infants showing early risk for Autism Spectrum Disorder (ASD). Participants will be randomized to receive an information, education and support group (Group) ESI intervention offered weekly, or a parent-implemented intervention (Individual) ESI intervention offered in twice-weekly, in combination with the Group ESI intervention.

Detailed description

Mounting evidence exists of the effectiveness of intensive early intervention for a substantial proportion of children with autism spectrum disorders (ASD). Furthermore, age of entry into intervention may be predictive of outcome. Children with ASD in intensive interventions beginning by 3.5 years of age had significantly better outcomes than those beginning after age 5. These findings support the importance of early identification and intervention for improving outcomes. There is very limited research on children with ASD under 3 years of age primarily because the median age for diagnosis in the US is 5.5 years. With advances in earlier screening and diagnosis, there is a pressing need to develop early intervention programs that are appropriate and effective with very young children with ASD. The Early Social Interaction (ESI) Project is an intervention program developed for toddlers at risk for ASD and their families as a model demonstration project funded by the United States Department of Education. ESI was designed to incorporate the National Research Council (NRC) recommendations within the context of a family-centered, natural-environments approach. The major components of ESI are: 1. routines-based intervention in natural environments 2. individualized curriculum 3. parent-implemented intervention The Emory Autism Center of Excellence (ACE) will recruit parent-infant dyads at 12 months of infant's age from a pool of High-Risk for Developing ASD younger siblings and from a pool of low risk infants being studied at the Emory ACE. Parents are involved in the intervention itself while the study outcome measures are focused on the infants that are receiving the different interventions (demographic and outcome data are not collected on the parents of the infants). Infant participants will be randomized to receive an ESI intervention delivered in a group setting, or an individual ESI intervention combined with the group ESI. The intervention will last 9 months and infants will be followed until they reach 36 months of age.

Interventions

BEHAVIORALGroup-ESI

The Group-ESI intervention consists of weekly small group meetings where families receive information about social communication, emotional regulation, play development, and behavioral challenges in toddler playgroups in a relaxed, supportive, child-friendly setting that provides the opportunity to talk with a professional and meet other parents.

BEHAVIORALIndividual-ESI

The Individual-ESI intervention consists of twice-weekly home-based individualized coaching sessions. Parents learn how to support their child's communication, social, and play skills in everyday routines, activities, and places. Individual-ESI begins with an initial home visit, followed by a month of program planning, 6 months of intervention implementation, and 2 months of generalization. During generalization, the clinician meets with the family in a variety of community settings to teach the parent how to implement strategies in new settings.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Months to 24 Months
Healthy volunteers
No

Inclusion criteria

* Participants are recruited from the Emory Autism Center of Excellence Center from a pool of younger siblings who are at high or low risk of developing ASD * For high-risk infants, a positive screen on 2 of 4 screening measures indicating the presence of diagnostic features of ASD by 12 months of age * For low-risk infants will be a positive screen on 3 of 4 screening measures * Families agree to twice monthly play group sessions for 9 months and 2-3 intervention sessions per week for 9 months (usually within work-day hours)

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Communication and Symbolic Behavior Scales (CSBS) ScoreBaseline (12 months of age, prior to treatment), 15, 21, and 24 months of ageSocial communication skills were measured with the Communication and Symbolic Behavior Scales (CSBS) Behavior Sample. Interactions between the child and caregiver were videotaped and later converted to scores. The standardized total score has a mean of 100 and standard deviation of 15. Scores below 100 indicate below average performance with the social, speech, and symbolic composites.
Autism Diagnostic Observation Schedule (ADOS) Score15, 24, and 36 months of ageAutism symptoms were measured with the Autism Diagnostic Observation Schedule, Second Edition which is the best gold standard diagnostic measure of ASD. The revised algorithms forming Social-Affect and Restricted Repetitive Behavior ratings of autism symptoms were used. A total of score of 1 to 3 indicates no signs of autism, a score of 4 or 5 suggests that the child may have autism spectrum disorder, while a score of 6 to 10 is indicative of autism.
Mullen Scales of Early Learning (MSEL) ScoreBaseline (12 months of age, prior to treatment), 24, and 36 months of ageThe Mullen Scales of Early Learning (MSEL) measures developmental level with standardized scores in five domains: Visual Reception, Receptive Language, Expressive Language, Fine Motor Skills, and Gross Motor Skills. Domain scores are represented in T-scores, with a mean of 50 and standard deviation of 10. A Verbal Composite score is calculated by averaging T-scores of the domains for Receptive and Expressive Language. A Nonverbal Composite score is calculated by averaging T-scores for Visual Reception and Fine Motor domains. Scores below 50 indicate below average performance.
Vineland Adaptive Behavior Scales, Second Edition (Vineland II) ScoreBaseline (12 months of age, prior to treatment), 24, and 36 months of ageThe Vineland II assesses adaptive behavior by providing a standard score in four domains of Communication, Daily Living Skills, Socialization, and Motor Skills. Domain scores and the Adaptive Behavior Composite score are standardized with a mean of 100 with a standard deviation of 15. Scores less than 100 indicate below average performance.

Other

MeasureTime frameDescription
Expressive Language PhaseBaseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of ageThe child's expressive language phase will be determined at each assessment based on the benchmarks delineated by Tager-Flusberg and colleagues and recommended for evaluating the efficacy and comparing outcomes across NIH-funded intervention studies. Based on multiple sources of information about language benchmarks, the language will be categorized as: Preverbal Communication, First Words, Word Combinations, or Sentences, to provide a clinically meaningful measure of language outcome.

Countries

United States

Participant flow

Recruitment details

Participants were recruited from Marcus Autism Center in Atlanta, Georgia, USA. Participant enrollment began in May 2013 and follow-up was completed by November 26, 2019.

Pre-assignment details

Infants were enrolled with a parent as parents were a necessary part of the intervention that the infants received. Parents are not considered to be participants who received a study intervention, thus, only infants are described in the modules for Participant Flow, Baseline Characteristics, Outcome Measures, and Adverse Events.

Participants by arm

ArmCount
Group-ESI
Infants 12 months of age at risk of developing ASD who were randomized to receive the Group-ESI intervention for 9 months
16
Individual-ESI Plus Group-ESI
Infants 12 months of age at risk of developing ASD who were randomized to receive Individual-ESI intervention in addition to the Group-ESI intervention for 9 months.
17
Total33

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up01
Overall StudyProtocol Violation01
Overall StudyWithdrawal by Subject41

Baseline characteristics

CharacteristicGroup-ESIIndividual-ESI Plus Group-ESITotal
Age, Categorical
<=18 years
16 Participants17 Participants33 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants0 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
15 Participants17 Participants32 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
3 Participants4 Participants7 Participants
Race (NIH/OMB)
More than one race
1 Participants2 Participants3 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
12 Participants11 Participants23 Participants
Region of Enrollment
United States
16 Participants17 Participants33 Participants
Sex: Female, Male
Female
5 Participants6 Participants11 Participants
Sex: Female, Male
Male
11 Participants11 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 17
other
Total, other adverse events
0 / 160 / 17
serious
Total, serious adverse events
0 / 160 / 17

Outcome results

Primary

Autism Diagnostic Observation Schedule (ADOS) Score

Autism symptoms were measured with the Autism Diagnostic Observation Schedule, Second Edition which is the best gold standard diagnostic measure of ASD. The revised algorithms forming Social-Affect and Restricted Repetitive Behavior ratings of autism symptoms were used. A total of score of 1 to 3 indicates no signs of autism, a score of 4 or 5 suggests that the child may have autism spectrum disorder, while a score of 6 to 10 is indicative of autism.

Time frame: 15, 24, and 36 months of age

Population: This analysis includes participants remaining in the study at the indicated time point who also completed this assessment. Due to scheduling conflicts with families, not all participants were able to complete every study assessment. If a study visit could not be scheduled within the visit window then that visit was skipped and the next assessment was scheduled.

ArmMeasureGroupValue (MEAN)Dispersion
Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score15 Months of Age3.88 score on a scaleStandard Deviation 2.03
Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score24 Months of Age5.14 score on a scaleStandard Deviation 2.69
Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score36 Months of Age3.79 score on a scaleStandard Deviation 2.12
Individual-ESI Plus Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score36 Months of Age4.53 score on a scaleStandard Deviation 3.56
Individual-ESI Plus Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score15 Months of Age3.75 score on a scaleStandard Deviation 2.24
Individual-ESI Plus Group-ESIAutism Diagnostic Observation Schedule (ADOS) Score24 Months of Age5.23 score on a scaleStandard Deviation 3
Primary

Communication and Symbolic Behavior Scales (CSBS) Score

Social communication skills were measured with the Communication and Symbolic Behavior Scales (CSBS) Behavior Sample. Interactions between the child and caregiver were videotaped and later converted to scores. The standardized total score has a mean of 100 and standard deviation of 15. Scores below 100 indicate below average performance with the social, speech, and symbolic composites.

Time frame: Baseline (12 months of age, prior to treatment), 15, 21, and 24 months of age

Population: This analysis includes participants remaining in the study at the indicated time point who also completed this assessment. Due to scheduling conflicts with families, not all participants were able to complete every study assessment. If a study visit could not be scheduled within the visit window then that visit was skipped and the next assessment was scheduled.

ArmMeasureGroupValue (MEAN)Dispersion
Group-ESICommunication and Symbolic Behavior Scales (CSBS) ScoreBaseline (12 months of age, prior to treatment)80.44 score on a scaleStandard Deviation 3.83
Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score21 Months of Age85.60 score on a scaleStandard Deviation 12.85
Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score15 Months of Age79.20 score on a scaleStandard Deviation 10.88
Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score24 Months of Age85.79 score on a scaleStandard Deviation 17.48
Individual-ESI Plus Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score15 Months of Age80.36 score on a scaleStandard Deviation 8.64
Individual-ESI Plus Group-ESICommunication and Symbolic Behavior Scales (CSBS) ScoreBaseline (12 months of age, prior to treatment)78.71 score on a scaleStandard Deviation 5.97
Individual-ESI Plus Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score24 Months of Age89.92 score on a scaleStandard Deviation 15.1
Individual-ESI Plus Group-ESICommunication and Symbolic Behavior Scales (CSBS) Score21 Months of Age91.20 score on a scaleStandard Deviation 11.81
Primary

Mullen Scales of Early Learning (MSEL) Score

The Mullen Scales of Early Learning (MSEL) measures developmental level with standardized scores in five domains: Visual Reception, Receptive Language, Expressive Language, Fine Motor Skills, and Gross Motor Skills. Domain scores are represented in T-scores, with a mean of 50 and standard deviation of 10. A Verbal Composite score is calculated by averaging T-scores of the domains for Receptive and Expressive Language. A Nonverbal Composite score is calculated by averaging T-scores for Visual Reception and Fine Motor domains. Scores below 50 indicate below average performance.

Time frame: Baseline (12 months of age, prior to treatment), 24, and 36 months of age

Population: This analysis includes participants remaining in the study at the indicated time point who also completed this assessment. Due to scheduling conflicts with families, not all participants were able to complete every study assessment. If a study visit could not be scheduled within the visit window then that visit was skipped and the next assessment was scheduled.

ArmMeasureGroupValue (MEAN)Dispersion
Group-ESIMullen Scales of Early Learning (MSEL) ScoreBaseline (12 months of age, prior to treatment) - Nonverbal Composite Score54.13 t-scoreStandard Deviation 5.66
Group-ESIMullen Scales of Early Learning (MSEL) Score24 Months of Age - Verbal Composite Score40.86 t-scoreStandard Deviation 14.2
Group-ESIMullen Scales of Early Learning (MSEL) Score24 Months of Age - Nonverbal Composite Score52.36 t-scoreStandard Deviation 6.34
Group-ESIMullen Scales of Early Learning (MSEL) Score36 Months of Age - Verbal Composite Score44.43 t-scoreStandard Deviation 12.94
Group-ESIMullen Scales of Early Learning (MSEL) Score36 Months of Age - Nonverbal Composite Score48.93 t-scoreStandard Deviation 13.73
Group-ESIMullen Scales of Early Learning (MSEL) ScoreBaseline (12 months of age, prior to treatment) - Verbal Composite Score37.50 t-scoreStandard Deviation 8.43
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) Score36 Months of Age - Nonverbal Composite Score47.13 t-scoreStandard Deviation 10.17
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) Score24 Months of Age - Verbal Composite Score45.19 t-scoreStandard Deviation 11.02
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) Score36 Months of Age - Verbal Composite Score43.63 t-scoreStandard Deviation 11.73
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) ScoreBaseline (12 months of age, prior to treatment) - Nonverbal Composite Score52.79 t-scoreStandard Deviation 8.78
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) Score24 Months of Age - Nonverbal Composite Score47.19 t-scoreStandard Deviation 10.7
Individual-ESI Plus Group-ESIMullen Scales of Early Learning (MSEL) ScoreBaseline (12 months of age, prior to treatment) - Verbal Composite Score37.03 t-scoreStandard Deviation 6.16
Primary

Vineland Adaptive Behavior Scales, Second Edition (Vineland II) Score

The Vineland II assesses adaptive behavior by providing a standard score in four domains of Communication, Daily Living Skills, Socialization, and Motor Skills. Domain scores and the Adaptive Behavior Composite score are standardized with a mean of 100 with a standard deviation of 15. Scores less than 100 indicate below average performance.

Time frame: Baseline (12 months of age, prior to treatment), 24, and 36 months of age

Population: This analysis includes participants remaining in the study at the indicated time point who also completed this assessment. Due to scheduling conflicts with families, not all participants were able to complete every study assessment. If a study visit could not be scheduled within the visit window then that visit was skipped and the next assessment was scheduled.

ArmMeasureGroupValue (MEAN)Dispersion
Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) ScoreBaseline (12 months of age, prior to treatment)87.69 score on a scaleStandard Deviation 8.51
Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) Score24 Months of Age90.64 score on a scaleStandard Deviation 8.91
Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) Score36 Months of Age90.13 score on a scaleStandard Deviation 10.75
Individual-ESI Plus Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) ScoreBaseline (12 months of age, prior to treatment)87.19 score on a scaleStandard Deviation 7.26
Individual-ESI Plus Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) Score24 Months of Age92.14 score on a scaleStandard Deviation 7.08
Individual-ESI Plus Group-ESIVineland Adaptive Behavior Scales, Second Edition (Vineland II) Score36 Months of Age84.57 score on a scaleStandard Deviation 6.21
Other Pre-specified

Expressive Language Phase

The child's expressive language phase will be determined at each assessment based on the benchmarks delineated by Tager-Flusberg and colleagues and recommended for evaluating the efficacy and comparing outcomes across NIH-funded intervention studies. Based on multiple sources of information about language benchmarks, the language will be categorized as: Preverbal Communication, First Words, Word Combinations, or Sentences, to provide a clinically meaningful measure of language outcome.

Time frame: Baseline (12 months of age, prior to treatment), 15, 21, 24, and 36 months of age

Population: Expressive language phase was to be coded based on the CSBS, however, this coding requires extensive time and effort by a trained staff member. As the study terminated early and research priorities shifted with the Coronavirus disease 2019 (COVID-19) pandemic, staffing was no longer available to review the video recordings specifically to code language phase. Data analyses for this study focused on addressing the primary aims of the study and data for this outcome were never created.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026